- Home
- CNET vs GLMD Comparison
CNET vs GLMD Comparison
Compare CNET & GLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNET
- GLMD
- Stock Information
- Founded
- CNET 2003
- GLMD 2000
- Country
- CNET Hong Kong
- GLMD Israel
- Employees
- CNET N/A
- GLMD N/A
- Industry
- CNET Advertising
- GLMD Biotechnology: Pharmaceutical Preparations
- Sector
- CNET Consumer Discretionary
- GLMD Health Care
- Exchange
- CNET Nasdaq
- GLMD Nasdaq
- Market Cap
- CNET 2.8M
- GLMD 3.0M
- IPO Year
- CNET N/A
- GLMD 2014
- Fundamental
- Price
- CNET $1.54
- GLMD $1.19
- Analyst Decision
- CNET
- GLMD Hold
- Analyst Count
- CNET 0
- GLMD 1
- Target Price
- CNET N/A
- GLMD N/A
- AVG Volume (30 Days)
- CNET 11.5K
- GLMD 4.8M
- Earning Date
- CNET 04-15-2025
- GLMD 05-29-2025
- Dividend Yield
- CNET N/A
- GLMD N/A
- EPS Growth
- CNET N/A
- GLMD N/A
- EPS
- CNET N/A
- GLMD N/A
- Revenue
- CNET $15,439,000.00
- GLMD N/A
- Revenue This Year
- CNET N/A
- GLMD N/A
- Revenue Next Year
- CNET N/A
- GLMD N/A
- P/E Ratio
- CNET N/A
- GLMD N/A
- Revenue Growth
- CNET N/A
- GLMD N/A
- 52 Week Low
- CNET $1.35
- GLMD $1.21
- 52 Week High
- CNET $4.53
- GLMD $23.80
- Technical
- Relative Strength Index (RSI)
- CNET 48.82
- GLMD 38.80
- Support Level
- CNET $1.45
- GLMD $1.16
- Resistance Level
- CNET $1.59
- GLMD $1.33
- Average True Range (ATR)
- CNET 0.08
- GLMD 0.14
- MACD
- CNET -0.01
- GLMD 0.00
- Stochastic Oscillator
- CNET 23.26
- GLMD 7.41
About CNET ZW Data Action Technologies Inc.
ZW Data Action Technologies Inc is engaged in providing Internet advertising, precision marketing, e-commerce online to offline (O2O) advertising and marketing services as well as the related data and technical services to small and medium enterprises in the PRC. It offers a variety channels of advertising and marketing services through its system, including distribution of the right to use search engine marketing services, provision of online advertising placements on its web portals, provision of ecommerce O2O advertising and marketing services and provision of other related value-added data and technical services to maximize market exposure and effectiveness for clients.
About GLMD Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.